Optimus Healthcare & Research Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.55 Cr
as on 15-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 43.50 Cr
as on 15-12-2024
- Revenue 28.74%
(FY 2022)
- Profit 119.32%
(FY 2022)
- Ebitda 19.12%
(FY 2022)
- Net Worth 3002.30%
(FY 2022)
- Total Assets 1.89%
(FY 2022)
About Optimus Healthcare & Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.55 Cr.
The company currently has active open charges totaling ₹43.50 Cr.
Bhushan Nemade, Bhushan Wani, and Rahul Bhamre serve as directors at the Company.
- CIN/LLPIN
U85310MH2016PTC287654
- Company No.
287654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Dhule, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Optimus Healthcare & Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushan Wani  | Managing Director | 15-Nov-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhushan Nemade | Director | 15-Nov-2016 | Current |
| Rahul Bhamre | Director | 15-Nov-2016 | Current |
Financial Performance of Optimus Healthcare & Research.
Optimus Healthcare & Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.74% increase. The company also saw a substantial improvement in profitability, with a 119.32% increase in profit. The company's net worth Soared by an impressive increase of 3002.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimus Healthcare & Research?
In 2021, Optimus Healthcare & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sankalp Speciality Healthcare Private LimitedActive 11 years 4 monthsBhushan Nemade is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Jan 2020 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 17 Sep 2018 | ₹21.50 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Aug 2018 | ₹20.00 Cr | Open |
How Many Employees Work at Optimus Healthcare & Research?
Optimus Healthcare & Research has a workforce of 51 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimus Healthcare & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Healthcare & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
